| Autor: |
Arteaga-Jacobo MC; Programa de Genética Humana, Institute of Biomedical Science (ICBM), Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile., Roco-Videla Á; Vicerectoria de Investigación e Innovación, Universidad Arturo Prat, Iquique 1110939, Chile.; Facultad de Medicina, Universidad Católica de la Santísima Concepción, Concepción 4030000, Chile., Villota Arcos C; Escuela de Nutrición y Dietética, Facultad de Ciencias de la Salud, Universidad Bernardo O'Higgins, Santiago 8370993, Chile., González-Hormazábal P; Programa de Genética Humana, Institute of Biomedical Science (ICBM), Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile., Gonzalo-Castro V; Programa de Genética Humana, Institute of Biomedical Science (ICBM), Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile., Pérez-Flores MV; Hospital San Juan de Dios, Santiago 8350488, Chile.; Hospital Luis Calvo Mackenna, Santiago 7500539, Chile. |
| Abstrakt: |
Background and Objectives : Congenital thyroid dyshormonogenesis is caused by alterations in the synthesis of thyroid hormones in a newborn. Additionally, 10 to 20% of these cases are hereditary, caused by defects in proteins involved in hormonal synthesis. One of the most common causes is mutations in the thyroid peroxidase (TPO) enzyme gene, an autosomal recessive disease. We aimed to detect mutations of the TPO gene in 12 Chilean patients with congenital hypothyroidism due to dyshormonogenesis (CHD) and to characterize these patients clinically and molecularly. Materials and Methods : Twelve patients under 20 years of age with CHD, controlled at San Juan de Dios Hospital in Santiago, Chile, were selected according to the inclusion criteria: elevated neonatal TSH, persistent hypothyroidism, and thyroid normotopic by imaging study. Those with deafness, Down syndrome, and central or transient congenital hypothyroidism were excluded. Blood samples were taken for DNA extraction, and the 17 exons and exon-intron junctions of the TPO gene were amplified by PCR. The PCR products were sequenced by Sanger. Results : Two possibly pathogenic mutations of the TPO gene were detected: c.2242G>A (p.Val748Met) and c.1103C>T (p.Pro368Leu). These mutations were detected in 2 of 12 patients (16.6%): 1 was compound heterozygous c.1103C>T/c.2242G>A, and the other was heterozygous for c.2242G>A. In the diagnostic confirmation test, both patients presented diffuse hyper-uptake goiter on thyroid scintigraphy and high TSH in venous blood (>190 uIU/mL). Conclusions : The frequency of patients with possibly pathogenic mutations in TPO with CHD was 16.6%. Its study would allow for genetic counseling to be offered to the families of affected patients. |
